City

Boston (1)

Condition

Metastatic NUT Carcinoma (2)

Unresectable NUT Carcinoma (2)

Metastatic Malignant Solid Neoplasm (1)

Unresectable Malignant Solid Neoplasm (1)

Overall Status

Suspended (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

abemaciclib (1)

bet bromodomain inhibitor zen-3694 (1)

biopsy (1)

cisplatin (1)

diagnostic imaging (1)

etoposide (1)

etoposide phosphate (1)

molibresib (1)

molibresib besylate (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

metastatic nut carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended

Metastatic Malignant Solid Neoplasm
+3 more

Abemaciclib
+3 more

Boston, Massachusetts

Dana-Farber - Harvard Cancer Center LAO

Sep 17, 2022

Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)

Withdrawn

Metastatic NUT Carcinoma
Unresectable NUT Carcinoma

Cisplatin
+4 more

(no location specified)

Sep 25, 2020